Achiron A - Search Results

1

Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod.

Achiron A, Mandel M, Gurevich M, Dreyer-Alster S, Magalashvili D, Sonis P, Dolev M, Menascu S, Harari G, Flechter S, Falb R. Achiron A, et al. J Neurol. 2022 May;269(5):2286-2292. doi: 10.1007/s00415-022-11030-0. Epub 2022 Mar 2. J Neurol. 2022. PMID: 35235002 Free PMC article. Clinical Trial.

2

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis.

Achiron A, Pras E, Gilad R, Ziv I, Mandel M, Gordon CR, Noy S, Sarova-Pinhas I, Melamed E. Achiron A, et al. Arch Neurol. 1992 Dec;49(12):1233-6. doi: 10.1001/archneur.1992.00530360031013. Arch Neurol. 1992. PMID: 1449400

3

Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study.

Achiron A, Rotstein Z, Noy S, Mashiach S, Dulitzky M, Achiron R. Achiron A, et al. Among authors: achiron r. J Neurol. 1996 Jan;243(1):25-8. doi: 10.1007/BF00878527. J Neurol. 1996. PMID: 8869383 Clinical Trial.

4

Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses.

Achiron A, Gabbay U, Gilad R, Hassin-Baer S, Barak Y, Gornish M, Elizur A, Goldhammer Y, Sarova-Pinhas I. Achiron A, et al. Neurology. 1998 Feb;50(2):398-402. doi: 10.1212/wnl.50.2.398. Neurology. 1998. PMID: 9484361 Clinical Trial.

5

Subacute thyroiditis in a patient with MS treated with interferon beta-1a.

Kreiss Y, Cohen O, Pras E, Achiron A. Kreiss Y, et al. Among authors: achiron a. Neurology. 1999 Oct 22;53(7):1606. doi: 10.1212/wnl.53.7.1606. Neurology. 1999. PMID: 10534282 No abstract available.

6

Multiple sclerosis-from probable to definite diagnosis: a 7-year prospective study.

Achiron A, Barak Y. Achiron A, et al. Arch Neurol. 2000 Jul;57(7):974-9. doi: 10.1001/archneur.57.7.974. Arch Neurol. 2000. PMID: 10891979 Clinical Trial.

7

[Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].

Achiron A, Miron S. Achiron A, et al. Ann Med Interne (Paris). 2000 May;151 Suppl 1:1S41-4. Ann Med Interne (Paris). 2000. PMID: 10896988 Review. French.

8

APOE genotype is a major predictor of long-term progression of disability in MS.

Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewczyk K, Birnbaum M, Michaelson DM, Korczyn AD. Chapman J, et al. Among authors: achiron a. Neurology. 2001 Feb 13;56(3):312-6. doi: 10.1212/wnl.56.3.312. Neurology. 2001. PMID: 11171894

9

Effect of interferon-beta-1b on cognitive functions in multiple sclerosis.

Barak Y, Achiron A. Barak Y, et al. Among authors: achiron a. Eur Neurol. 2002;47(1):11-4. doi: 10.1159/000047940. Eur Neurol. 2002. PMID: 11803186 Clinical Trial.

10

Interaction of disease-related antigen-reactive T-cell lines from multiple sclerosis patients with type IV collagen: role of integrin VLA-1 and effects of irradiation.

Bank I, Achiron A, Levie G, Koltakov A, Mandel M. Bank I, et al. Among authors: achiron a. J Clin Immunol. 2002 May;22(3):153-63. doi: 10.1023/a:1015472013500. J Clin Immunol. 2002. PMID: 12078857

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters